These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 10394110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cathepsin B and L in nephron segments of rats with puromycin aminonucleoside nephrosis.
    Olbricht CJ, Cannon JK, Tisher CC.
    Kidney Int; 1987 Sep; 32(3):354-61. PubMed ID: 3669494
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I, Nakamura T, Tomino Y, Koide H.
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activities of lysosomal enzymes in isolated glomeruli. Alterations in experimental nephrosis.
    Velosa JA, Shah SV, Ou SL, Abboud HE, Dousa TP.
    Lab Invest; 1981 Dec; 45(6):522-6. PubMed ID: 7321525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis.
    Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA.
    Kidney Int; 1991 Dec; 40(6):1020-31. PubMed ID: 1762303
    [Abstract] [Full Text] [Related]

  • 11. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J, Muller EW, van Goor H, Weening JJ, Elema JD.
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [Abstract] [Full Text] [Related]

  • 12. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 13. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    J Lab Clin Med; 1987 May 28; 109(5):538-44. PubMed ID: 3572200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
    Tofovic SP, Rominski BR, Bastacky S, Jackso EK, Kost CK.
    Ren Fail; 2000 Mar 28; 22(2):159-79. PubMed ID: 10803761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal structural abnormalities following recovery from acute puromycin nephrosis.
    Rasch R, Nyengaard JR, Marcussen N, Meyer TW.
    Kidney Int; 2002 Aug 28; 62(2):496-506. PubMed ID: 12110010
    [Abstract] [Full Text] [Related]

  • 19. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Nov 28; 54(2):279-82. PubMed ID: 3538253
    [Abstract] [Full Text] [Related]

  • 20. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.
    Br J Pharmacol; 2003 Jun 28; 139(4):823-31. PubMed ID: 12813006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.